In human pancreatic ductal adenocarcinoma, disruption of this interaction by blockade of NKG2A enhances NK and CD8-mediated tumor cell killing in vitro, and also prevents tumor metastasis in vivo (26). Here, CD8A is linked to pancreatic ductal adenocarcinoma.